We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novavax Kicks Off Phase 3 Trial of COVID-19 Vaccine in UK
Novavax Kicks Off Phase 3 Trial of COVID-19 Vaccine in UK
Novavax yesterday launched a phase 3 clinical trial of its COVID-19 vaccine in the UK, becoming the latest drugmaker to bring a vaccine candidate to late-stage testing.